Skip to main content
Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
46.62
+0.40 (0.87%)
At close: Apr 28, 2026, 4:00 PM EDT
45.76
-0.86 (-1.84%)
After-hours: Apr 28, 2026, 6:34 PM EDT

Corcept Therapeutics Revenue

In the year 2025, Corcept Therapeutics had annual revenue of $761.41M with 12.79% growth. Corcept Therapeutics had revenue of $202.13M in the quarter ending December 31, 2025, with 11.12% growth.

Revenue (ttm)
$761.41M
Revenue Growth
+12.79%
P/S Ratio
6.57
Revenue / Employee
$1,043,023
Employees
730
Market Cap
5.00B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025761.41M86.37M12.79%
Dec 31, 2024675.04M192.67M39.94%
Dec 31, 2023482.38M80.52M20.04%
Dec 31, 2022401.86M35.88M9.80%
Dec 31, 2021365.98M12.10M3.42%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PTC Therapeutics 1.73B
Legend Biotech 1.03B
Apellis Pharmaceuticals 1.00B
Amicus Therapeutics 634.21M
TG Therapeutics 616.29M
Mirum Pharmaceuticals 521.31M
Ligand Pharmaceuticals 268.09M
Xenon Pharmaceuticals 7.50M
Revenue Rankings

CORT News

More News